Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK.
Newell
D R
DR
Northern Institute for Cancer Research, University of Newcastle upon Tyne, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.
Searle
K M
KM
Westwood
N B
NB
Burtles
S S
SS
D000970:Antineoplastic Agents / Q000266:history* / Q000494:pharmacology / Q000627:therapeutic use; D026661:Clinical Trials Data Monitoring Committees / Q000266:history*; D017321:Clinical Trials, Phase I as Topic / Q000266:history*; D017322:Clinical Trials, Phase II as Topic / Q000266:history*; D005380:Financing, Government / Q000266:history; D006291:Health Policy / Q000266:history; D049673:History, 20th Century; D006801:Humans; D007391:International Cooperation / Q000266:history; D009369:Neoplasms / Q000188:drug therapy / Q000266:history*; D012107:Research Design; D006113:United Kingdom
D000970:Antineoplastic Agents